Firefighter Asbestos Exposure at Department Store Fire

LegalView Informs Readers of Potential Firefighter Asbestos Exposure at a Recent Department Store Fire

LegalView continues to inform readers of the most recent mesothelioma and asbestos news updates on its mesothelioma blog. A recent department store fire has nearly 60 firefighters worried about potential exposure to asbestos

Denver, CO - January 6, 2008 -- LegalView.com, the number one resource for everything legal on the Web, reported on mesothelioma blog that nearly 60 firefighters in a Connecticut town may have been exposed to asbestos after a recent department store fire.

Asbestos is a deadly substance that was used in the construction of homes, schools, government buildings and even in department stores or other commercial constructions. When individuals are exposed to asbestos fibers and asbestos dust they become at risk for mesothelioma cancer. Mesothelioma is a deadly form of cancer that takes decades to reveal itself, by which time, it is often too late to offer treatment for the cancer. Many individuals who have worked in the construction, mining or shipyard industry have been associated with asbestos exposure. If you feel you or your loved one may be in danger of asbestos exposure it is important to seek help immediately. The sooner mesothelioma cancer is found the better the chance is of treating it. After consulting with a mesothelioma doctor, use LegalView's resources to reach a mesothelioma lawyer who may also be able to provide insight into the case.

The department store fire occurred in New Haven, Connecticut. Sixty firefighters had reportedly fought the fire for hours on end with air packs that lasted only 30 minutes. The blog reports that debris from the fire was sent to the Department of Public Health and several samples were found to have tested positive for asbestos. For individuals who feel they have been previously exposed to asbestos, it is important to contact an experienced mesothelioma attorney to receive a consultation.

LegalView offers other legal resources including finding information on traumatic brain injury accidents or an auto accident injury. Millions of Americans are affected by these tragic accidents each and every day and LegalView stands by those suffering from tragedy. LegalView also offers information on how to locate an experience all-terrain vehicle law firm who can provide assistance during a rollover accident.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://www.LegalView.com

Cancer Drug Synergy Found With Biothera And Avastin

Biothera Drug Synergistic with Avastin® Against Cancer, Study Finds

EAGAN, Minn.- February 28, 2008 -Biothera's Imprime PGGT increased the effectiveness of Avastin® (bevacizumab), a monoclonal antibody approved for the treatment of metastatic colorectal, breast and non-small cell lung cancer, according to a new preclinical study published in the current issue of Clinical Cancer Research.

Researchers in the Tumor Immunobiology Program of the James Graham Brown Cancer Center, University of Louisville, Kentucky, studied the synergistic effects of Imprime PGG in combination with Avastin in a xenograft mouse model where human ovarian cancer cells were implanted into the mice. In the treatment group receiving both Imprime PGG and Avastin, 86% of the mice survived 100 days compared with only 43% in the group receiving Avastin alone.

"Our study is the first to demonstrate that Avastin, an anti-angiogenic agent, co-administered with Imprime PGG, an agent that enhances innate immune effector cell function, results in synergistic anti-tumor effects," said Carolina Salvador, M.D., a clinical instructor at the James Graham Brown Cancer Center. "This type of combination strategy has significant clinical implications and deserves further investigation."

"These results are consistent with our previous research with Imprime PGG and various monoclonal antibodies in numerous cancer indications," said Daniel K. Conners, president of Biothera's Pharmaceutical Group. "We are now working to demonstrate the safety and efficacy of these novel cancer therapies in the clinic."

Biothera is currently conducting a clinical trial with metastatic colorectal cancer patients receiving a combination therapy of Imprime PGG, Erbitux® (cetuximab), a monoclonal antibody from ImClone Systems, and Irinotecan, a chemotherapy drug from Pfizer. The results of the trial are expected later in 2008. The company also plans to initiate a clinical study in lung cancer patients this year using a combination of Imprime PGG, Avastin and two chemotherapy drugs.

The title of the new Clinical Cancer Research paper is "Yeast-Derived ?-Glucan Augments the Therapeutic Efficacy Mediated by Anti-Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models." The authors are Carolina Salvador, Bing Li, Richard Hansen, Daniel E. Cramer, Maiying Kong and Jun Yan.

About Imprime PGGT

Imprime PGG is a biological response modifier that enhances specific innate immune cell responses. Biothera has completed two Phase I clinical trials under its cancer Investigational New Drug (IND) application for the use of Imprime PGG in combination with anti-cancer monoclonal antibodies. Under a separate IND, the company also has completed a Phase I/II trial with Imprime PGG in combination with a hematopoietic growth factor.

About Avastin®

Avastin was the first anti-angiogenesis therapy approved by the FDA and with last week's approval, is now approved for the treatment of the three leading causes of cancer death in the U.S.: metastatic colorectal cancer, advanced non-squamous, non-small cell lung cancer and metastatic HER2-negative breast cancer. Avastin is a product of Genentech.

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company's primary focus is developing pharmaceuticals that engage the innate immune system to fight cancer. Website: www.biotherapharma.com.

Contacts

Biothera, the Immune Health Company
David Walsh, 651-256-4606
VP, Communications
dwalsh@biotherapharma.com

---

On the list of sites with mesothelioma Minnesota is gaining attention as a location with an increased number of cases diagnosed.

Mesothelioma Symptoms And Steps To Making A Diagnosis

I found another good mesothelioma video that is by an actual mesothelioma doctor. His name is Dr. Case and he talks about what the symptoms of mesothelioma are and what is needed to make a positive diagnosis of the disease. He uses mostly plain talk and is easy to understand. The video is part of a free video that is offered at http://www.mesodvd.com/.